ResearchStructure intelligence
Structure priors for peptide review.
This explorer shows folded candidates, fold families, structural novelty, and rerank context from Protean's public structure export. These are computational priors used to prioritize review. They do not establish biological activity, binding, stability, safety, efficacy, or clinical readiness.
Candidates
15
Predicted fold files
70
Fold families
1
Sequence families
11
Structure-space dashboard
Public fold context.
The counts below summarize how published candidates are represented in the structure export. They are review context, not outcome claims.
Fold mode
Structural tiers
Rerank decisions
Candidate rows
Ranked canonical structure candidates.
Rows are ordered strongest to weakest by public computational structure evidence: predicted-fold availability, pLDDT, compactness, confidence buckets, and novelty. This ordering is a review view, not an activity ranking.
HQMAQHCDDCDQFPTDCG
phenotype_first_unknown_target
seqfam:7d29af0f · fold_cluster_000 · novelty 1.000
KPADSQHHNQNQRHHQW
phenotype_first_unknown_target
seqfam:21d0d333 · fold_cluster_000 · novelty 1.000
WPIWQPHQTQCGSGGGC
phenotype_first_unknown_target
seqfam:c72e48a6 · fold_cluster_000 · novelty 1.000
GHQMQHHCDDSQPTDCWP
phenotype_first_unknown_target
seqfam:4e57da74 · fold_cluster_000 · novelty 1.000
MGGEVLPQQPVQSGQEQH
immune_modulator
seqfam:ed5ee6fc · fold_cluster_000 · novelty 0.000
MGGEVLPQQPVQSAQEQH
immune_modulator
seqfam:ed5ee6fc · fold_cluster_000 · novelty 0.000
FPDNGDQQQEMGKH
immune_modulator
seqfam:66695217 · fold_cluster_000 · novelty 0.000
WPQEMGTSWPPNQCQ
immune_modulator
seqfam:5af04825 · fold_cluster_000 · novelty 0.000
ILPQEMGGDQQQEMGKH
immune_modulator
seqfam:aeda3f9c · fold_cluster_000 · novelty 0.000
RPEMGGERAQQPPRANT
phenotype_first_unknown_target
seqfam:3f10d9ca · fold_cluster_000 · novelty 0.000
WPQEMGTQWPPNQWQ
immune_modulator
seqfam:5af04825 · fold_cluster_000 · novelty 0.000
FPDNMKFFEPCPPNQ
gpcr_peptide
seqfam:66695217 · fold_cluster_000 · novelty 0.000
WPQEMGTSWPPNQWQ
immune_modulator
seqfam:5af04825 · fold_cluster_000 · novelty 0.000
PPNQTSWPPNGQGTQWPG
gpcr_peptide
seqfam:80cb2c9d · fold_cluster_000 · novelty 0.000
DCDQTNWPCGGQQHCDKA
phenotype_first_unknown_target
seqfam:1d06061d · fold_cluster_000 · novelty 0.000
Predicted fold ranking
ESMFold2 sidecar structures, best to worst.
These public sidecar folds are sorted by mean pLDDT with penalties for very-low-confidence residues. They expand the visible structure inventory without making experimental-structure or biological-activity claims.
Structurally novel
Novelty sorted for review.
Novelty scores are structure-space signals used to rank what deserves attention next. They are not assay outcomes.
GHQMQHHCDDSQPTDCWP
phenotype_first_unknown_target
seqfam:4e57da74 · fold_cluster_000 · novelty 1.000
HQMAQHCDDCDQFPTDCG
phenotype_first_unknown_target
seqfam:7d29af0f · fold_cluster_000 · novelty 1.000
KPADSQHHNQNQRHHQW
phenotype_first_unknown_target
seqfam:21d0d333 · fold_cluster_000 · novelty 1.000
WPIWQPHQTQCGSGGGC
phenotype_first_unknown_target
seqfam:c72e48a6 · fold_cluster_000 · novelty 1.000
ILPQEMGGDQQQEMGKH
immune_modulator
seqfam:aeda3f9c · fold_cluster_000 · novelty 0.000
RPEMGGERAQQPPRANT
phenotype_first_unknown_target
seqfam:3f10d9ca · fold_cluster_000 · novelty 0.000
FPDNMKFFEPCPPNQ
gpcr_peptide
seqfam:66695217 · fold_cluster_000 · novelty 0.000
WPQEMGTSWPPNQWQ
immune_modulator
seqfam:5af04825 · fold_cluster_000 · novelty 0.000
Families and campaigns
The cohort view.
Fold families, sequence families, and campaigns keep candidate context visible across the public export.
Truth boundary
Structure metrics are computational priors, not biological proof. Predicted folds (ESMFold) and deterministic sequence-only proxies prioritize candidates for review; they do not establish biological activity, binding, stability, efficacy, safety, patentability, or clinical readiness. Wet-lab validation and human review are the downstream reality check.